Preview: BioCardia's Earnings
Portfolio Pulse from Benzinga Insights
BioCardia (NASDAQ:BCDA) is scheduled to release its quarterly earnings report on March 27, 2024, with an estimated EPS of $-0.11. Investors are looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 5.75% drop. Currently, BioCardia's shares are trading at $0.405, marking an 80.07% decline over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
March 26, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BioCardia is expected to report an EPS of $-0.11 for the upcoming earnings, with investors hoping for positive guidance. The stock has seen significant volatility post-earnings in the past, and is currently down 80.07% over the last year.
BioCardia's upcoming earnings report is crucial given its past performance and current stock price decline. While an earnings beat and positive guidance could provide short-term price support, the long-term trend shows significant bearish sentiment. The mixed impact of past earnings on the stock price suggests uncertainty in predicting the short-term direction post-earnings, hence a neutral score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100